Results 101 to 110 of about 4,695 (214)

Noninvasive approach for the management of hemolytic disease of the fetus

open access: yes, 2009
Hemolytic disease of the fetus and newborn (HDFN) is due to maternal alloantibodies directed against paternally inherited antigens on fetal red cells, and it is still a problem in affected pregnancies despite the routine use of anti-D immunoglobulin ...
Soothill, PW   +3 more
core   +1 more source

CHALLENGES IN NEONATAL HEMATOLOGY

open access: yesSlovenska pediatrija
Although the aetiology of the most common haematological disorders of the newborn has been known for decades, the question of the most optimal treatment is still a challenge in clinical practice.
Jana Lozar Krivec
doaj   +1 more source

Unraveling complexity: A case report on ABO hemolytic disease of the fetus newborn in a preterm neonate and delayed hemolytic transfusion reaction in the beta thalassemic mother due to alloanti kidd a antibody

open access: yesAsian Journal of Transfusion Science
ABO hemolytic disease of the fetus and newborn (HDFN) generally occurs due to transplacental passage of maternal IgG ABO antibodies causing fetal and newborn red cell hemolysis.
V. K. Nayana   +5 more
doaj   +1 more source

Thrombocytopenia in Pregnancy: A 5‐Year Analysis of Characteristics and Practices From a Tertiary Academic Center

open access: yesInternational Journal of Laboratory Hematology, Volume 48, Issue 6, Page 1320-1329, December 2026.
ABSTRACT Background Moderate‐to‐severe thrombocytopenia (platelet count < 100 × 109/L) occurs in fewer than 1% of pregnancies, posing management challenges, particularly surrounding eligibility for neuraxial anesthesia. Although recent anesthesia guidelines recommend a platelet threshold ≥ 70 × 109/L, outcomes data applying these recommendations in ...
Mackenzie E. Lemieux, Ming Y. Lim
wiley   +1 more source

P-Selectin, Vascular Endothelial Cadherin, and Vascular Cell Adhesion Molecule-1 as Novel Biomarkers for ABO Hemolytic Disease of the Fetus and Newborn

open access: yesAnalytical Cellular Pathology
Conclusion: PS, VCAM-1, and VE-Cad provide experimental evidence for prenatal screening, diagnosis, early prevention and treatment of ABO-HDFN.
Weichun Tang   +3 more
doaj   +1 more source

Hemolytic Disease of the Fetus and Newborn Caused by Maternal Alloanti-Fy(a)

open access: yesCureus
Hemolytic disease of the fetus and newborn (HDFN) is commonly attributed to maternal antibodies against fetal red blood cell antigens, with anti-D being the most frequent cause. However, other antibodies, such as anti-Fya from the Duffy blood group system, can also lead to HDFN, although they are less commonly reported.
Robins, Rowena D.L.   +3 more
openaire   +2 more sources

When the Antibiogram Offers Nothing Else: Ceftriaxone–Sulbactam–Disodium EDTA With Intravenous Colistin in Two Neonates With Metallo‐β‐Lactamase‐Producing Acinetobacter baumannii Meningitis

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Two neonates with metallo‐β‐lactamase‐producing Acinetobacter baumannii meningitis, resistant to every tested alternative, received ceftriaxone–sulbactam–disodium EDTA plus intravenous colistin, which, to our knowledge, represents the first reported neonatal use of this combinations. Cultures were sterilized by day 7; both survived with normal
Naini Puri   +5 more
wiley   +1 more source

Anti-D-induced severe hemolytic disease of the newborn in an Omani newborn born a rhesus-positive mother

open access: yes, 2018
Hemolytic disease of the fetus and newborn (HDFN) due to anti-D antibodies is a well-known complication of rhesus (Rh) incompatibility, encountered in D-positive babies born to alloimmunized D-negative mothers who have been sensitized during previous ...
Hanan F. Nazir   +5 more
core   +1 more source

Hemolytic Disease of the Fetus and Newborn in an Integrated Health Care System

open access: yesAmerican Journal of Perinatology
AbstractHemolytic disease of the fetus and newborn (HDFN) is associated with significant infant morbidity and mortality. Characteristics of pregnancies impacted by HDFN are not well understood. Therefore, this study examines maternal and infant characteristics based on HDFN status in a large, integrated health care system in the United States.This was ...
Michael J. Fassett   +12 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy